Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec la Dre Catherine Labbé, pneumologue spécialisée en oncologie pulmonaire à l'Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), au sujet de tout ce qu'il faut savoir sur le dépistage du cancer du poumon : qui est admissible, quels sont les critères et pourquoi est-il important de se faire dépister si vous présentez un risque élevé ?

In our new series called Perspectives on Lung Cancer, Dr. Paul Wheatley-Price sits down with two guests, both with a depth of experience in ALK+ lung cancer, which represents about 4-8% of all lung cancer cases in Canada. Dr. Cheryl Ho, medical oncologist at BC Cancer, provides her perspective as a physician treating these types of cancers in her daily practice, while Katie Hulan shares her journey as a patient diagnosed with ALK+ lung cancer in 2021, navigating the healthcare system, and her path to launching ALK Positive Canada to advocate for better awareness of this subtype of lung cancer.

Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec le Dr Kevin Jao, coprésident du comité médical consultatif de Cancer pulmonaire Canada et hémato-oncologue à l'Hôpital du Sacré-Cœur-de-Montréal. Ils présentent Cancer pulmonaire Canada, tout le soutien et les ressources disponibles pour les Canadiens touchés par le cancer du poumon, et mettent particulièrement l'accent sur le Mois de la sensibilisation au cancer du poumon.

In this episode, Dr. Paul Wheatley-Price is back for our annual recap of the IASLC 2025 World Conference on Lung Cancer (WCLC), which took place in Barcelona, Spain in early September. He is joined by two special guests, Dr. Barbara Melosky, Professor of Medicine at UBC and Medical Oncologist at BC Cancer, and Dr. Peter Ellis, Professor of Oncology at McMaster University and Medical Oncologist at Juravinski Cancer Center. They chat about all the updates for treatments like osimertinib for EGFR+ lung cancer, immunotherapy for small-cell lung cancer, and promising new treatments like for HER2 and ADCs coming down the pipeline.

Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec Lise Boilard, qui a reçu un diagnostic de cancer du poumon en 2017 à l'âge de 44 ans, et sa médecin traitante, la Dre Myriam Bouchard, radio-oncologue au Centre hospitalier de l'université de Sherbrooke. Lise partage son parcours inspirant face au cancer du poumon, la relation unique qu'elles ont nouée ensemble, ainsi que l'expertise du Dre Bouchard sur la maladie et la manière dont les patients peuvent mener une vie épanouie tout en gérant les symptômes et les traitements.

In this episode, Dr. Paul Wheatley-Price chats with Dr. Bettina Hamelin, President & CEO of Innovative Medicines Canada (IMC) - the national association representing the voice of Canada’s innovative pharmaceutical industry. They talk about what IMC does, the role of pharma in drug development and access, opportunities for collaboration between patients, clinicians, and industry, and the drug approval process in Canada.

Learn more about Innovative Medicines Canada at https://innovativemedicines.ca/

In this episode, Dr. Paul Wheatley-Price chats with Dr. Arielle Elkrief, Medical Oncologist, Co-Director of the CHUM Microbiome Center, and Clinician-Scientist at the University of Montreal. They discuss everything about the microbiome and gut health - what is the microbiome, why it's important in cancer and treatments, tips for a healthy microbiome, antibiotics, and even "poop pills".

In this episode, Dr. Paul Wheatley-Price is back for another update into all the newest highlights from recent clinical trials for EGFR-positive lung cancer treatments. Dr. Stephen Liu is the Director of Thoracic Oncology and Professor of Medicine at Georgetown University in Washington, DC, and he co-hosts his own podcast with the IASLC, "Lung Cancer Considered". They are also joined by Emi Bossio, a passionate patient advocate who lives with EGFR+ lung cancer and has a number of roles, including as a member on LCC's Board of Directors.

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Andrew Robinson and Dr. Nathalie Daaboul on all the highlights coming out of this year's 2025 ASCO Conference, held in Chicago back in June. They discuss major developments in treatment for small cell lung cancer (SCLC), updates in immunotherapy, and a couple of unique drugs coming down the pipeline.

Dr. Robinson is a Medical Oncologist and Associate Professor at Queen's University in Kingston, ON. Dr. Daaboul is a Medical Oncologist at L'Hôpital Charles Lemoyne in Montreal, Associate Professor at the University of Sherbrooke, and also the host of the Lung Cancer Voices podcast series in French!

In this episode, Dr. Paul Wheatley-Price chats with Dr. Adrian Sacher on everything there is to know about KRAS lung cancer. What is KRAS lung cancer, how is it tested, and what it means in terms of treatment options for those who have this subtype of lung cancer. Dr. Adrian Sacher is a Thoracic Medical Oncologist at the Princess Margaret Cancer Centre and Assistant Professor in the Departments of Medicine & Immunology at the University of Toronto.